icotec Medical Inc.
$604.4K 1,344 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Endo Pharmaceuticals Inc.
Endo Pharmaceuticals Inc. reported $603,360.60 across General Payments, Research, and Ownership to 4,960 physicians and teaching hospitals across 4,968 transactions.
- $603.4K
- All-tracks total
- 4,968
- Transactions
- 4,960
- Recipients
- −$1.4M
- General Payments vs PY2023
Endo Pharmaceuticals Inc. reported $603,360.60 across all CMS Open Payments tracks (General + Research + Ownership) to 4,960 physicians and teaching hospitals in Program Year 2024 - ranking #724 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $579,807.93, averaging $121.65 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer endo-pharmaceuticals-inc Endo Pharmaceuticals Inc.
$603.4K · #724/1,925 · 0.0% industry · PY2024
- TOT $603.4K
- RANK #724
- SHARE 0.0%
- TXN 4,968
- RCP 4,960
- CAT 6
- GEN $579.8K
- ΔGEN −$1.4M
- TOP1 6.2%
- PY 2024
Volume peers
Nearest volume peer: icotec Medical Inc. ($604.4K)
Endo Pharmaceuticals Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Endo Pharmaceuticals Inc.'s CMS-reported General Payments decreased by $1.4M (−70.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ENDO PHARMACEUTICALS INC.PY2023: ENDO PHARMACEUTICALS INC.PY2024: Endo Pharmaceuticals Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,952,230.68
- PY2024
- $579,807.93
What the Data Shows for Endo Pharmaceuticals Inc.
In Program Year 2024, Endo Pharmaceuticals Inc. reported $603,360.60 in payments to 4,960 physicians and teaching hospitals across 4,968 individual transactions, an average of $121.45 per transaction and $121.65 per recipient. That total places Endo Pharmaceuticals Inc. at rank #724 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
"Consulting Fee" leads the 6-category general-payment breakdown below at $198.4K (34.2% of General Payments, 36 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 6 types of general payments, Endo Pharmaceuticals Inc.'s largest category was "Consulting Fee" at $198.4K - 34.2% of General Payments.
Endo Pharmaceuticals Inc. reports 6 general-payment categories - the top three are Consulting Fee (34.2%), Compensation for Services Other Than Consulting (23.8%), and Food and Beverage (21.8%). The remaining 3 categories make up 20.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Endo Pharmaceuticals Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $198.4K | 36 | 34.2% |
| Compensation for Services Other Than Consulting | $138.1K | 61 | 23.8% |
| Food and Beverage | $126.5K | 4,663 | 21.8% |
| Grant | $57.0K | 3 | 9.8% |
| Travel and Lodging | $50.4K | 195 | 8.7% |
| Space Rental or Facility Fees | $9.5K | 2 | 1.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $150,930.70 (26.0%) of $579,807.93 in this company's General Payments records across 3,076 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Endo Pharmaceuticals Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Damon Adamany
$35,847.32 across 41 reported transactions
- 2
Prosper Benhaim
$35,673.32 across 33 reported transactions
- 3
Cleveland Clinic Hospital
$35,000.00 across 1 reported transactions
- 4
Michael Garcia
$22,424.06 across 2 reported transactions
- 5
University of Washington Med Ctr
$21,986.00 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Endo Pharmaceuticals Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Endo Pharmaceuticals Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Endo Pharmaceuticals Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Cala Health, Inc.
$602.0K 123 recipients
Compare payment profiles
Arena Pharmaceuticals, Inc.
$606.7K 6 recipients
Compare payment profiles
OrthoFundamentals, LLC
$607.3K 15 recipients
Compare payment profiles
Bone Support Inc.
$613.3K 1,376 recipients
Compare payment profiles
Aroa Biosurgery Incorporated
$591.0K 3,872 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.